Importantly, as with single DMR analysis, many of these differences were also seen when comparing CRC tumor and NAT, suggesting that signaling pathway aberrations are somewhat consistent between FAP normal crypt epithelium and tumor samples. The gene discussed is BRD2; the disease is neoplasm.